Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue

Nutrition and Cancer

Volumn 66, Issue 2, 2014, Pages 270-277

  Qin, Wenyi ^a   Zhang, Ke ^b   Clarke, Kaitlin ^b   Weiland, Timothy ^b   Sauter, Edward R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; MICRORNA; MICRORNA 129; MICRORNA 204; MICRORNA 21; MICRORNA 489; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST; BREAST CARCINOGENESIS; BREAST TUMOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RNA METHYLATION; THERAPY EFFECT;

ANIMALIA; RATTUS; RODENTIA;

ANIMALS; AZACITIDINE; BREAST; BREAST NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; ESTROGENS; FEMALE; MICRORNAS; RATS; RATS, INBRED ACI; STILBENES;

EID: 84895078313     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.868910     Document Type: Article

References (31)

1. Baylin SB and Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6, 107-116, 2006. (Pubitemid 43361543)
2. Klose RJ and Bird AP: Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences 31, 89-97, 2006. (Pubitemid 43221841)
3. Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, et al.: An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 277, 28176-28181, 2002. (Pubitemid 34966771)
4. Ruhlen RL, Willbrand DM, Besch-Williford CL, Ma L, Shull JD, et al.: Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI. COP-Ept2 rat model. Breast Cancer Research and Treatment 117, 517-524, 2009.
5. Subbaramaiah K, Chung WJ, Michaluart P, Tanabe T, Telang N, et al.: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273, 21875-21882, 1998. (Pubitemid 28405365)
6. Mgbonyebi OP, Russo J, and Russo IH: Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12, 865-869, 1998. (Pubitemid 28133580)
7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220, 1997. (Pubitemid 127696281)
8. Qin W, Zhu W, and Sauter ER: Resveratrol induced DNA methylation in ER+ breast cancer. Proc Am Assn Cancer Res 96, 2750A, 2005.
9. Zhu W, Qin W, Zhang K, Rottinghaus GE, Chen YC, et al.: Transresveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer 64, 393-400, 2012.
10. Izzotti A, Cartiglia C, Steele VE, and De Flora S:MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutation Research/Reviews in Mutation Research 751, 287-303, 2012.
11. Dhar S, Hicks C, and Levenson AS: Resveratrol and prostate cancer: promising role for microRNAs. Mol Nutr Food Res 55, 1219-1229, 2011.
12. Qin W, Zhu W, Zhang K, Clarke K, and Sauter ER: Resveratrol decreases tumor foramtion in a human relevant animal model of breast cancer. 11th Annual Conference, Frontiers of Cancer Prevention Research, 2012.
13. Patel K, Dickson J, Din S, Macleod K, Jodrell D, et al.: Targeting of 5- aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Research 38, 4313-4324, 2010.
14. Sandhu R, Rivenbark AG, and Coleman WB: Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b. Breast Cancer Research and Treatment 131, 385-399, 2012.
15. Pereira MA, Wang W, Kramer PM, Kramer PM, and Tao L: DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. Cancer Letters 212, 145-151, 2004. (Pubitemid 38997970)
16. Tsai HC, Li H, Van Neste L, Cai Y, and Robert C: Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21, 430-446, 2012.
17. Chik F and Szyf M: Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis 32, 224-232, 2011.
18. Veeck J and Esteller M: Breast cancer epigenetics: from DNA methylation to microRNAs. Journal of Mammary Gland Biology and Neoplasia 15, 5-17, 2010.
19. Lancon A, Kaminski J, Tili E, Michaille JJ, and Latruffe N: Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem 60, 8783-8789, 2012.
20. Lopez-Serra P and Esteller M: DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31, 1609-1622, 2012.
21. Suzuki H, Maruyama R, Yamamoto E, and Kai M: DNA methylation and microRNA dysregulation in cancer. Molecular Oncology 6, 567-578, 2012.
22. Malumbres M: miRNAs and cancer: An epigenetics view. Molecular Aspects of Medicine 34, 863-874, 2013.
23. Kaminski J, Lancon A, Tili E, Aires, V, and Demarquoy, J: Dietary resveratrol modulates metabolic functions in skeletal muscle cells. J Food Drug Anal 20(Suppl. 1), 398-401, 2012.
24. Khan SI, Aumsuwan P, Khan IA, Walker LA, and Dasmahapatra AK: Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chemical Research in Toxicology 25, 61-73, 2012.
25. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, et al.: MicroRNA- 221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283, 29897-29903, 2008.
26. Gong M, Ma J, Li M, Zhou M, Hock JM, et al.: MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro-oncology 14, 1007-1017, 2012.
27. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, et al.: Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 130, 1036-1045, 2012.
28. Lee JA, Lee HY, Lee ES, Kim I, and Bae JW: Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast. Journal of Breast Cancer 14, 269-275, 2011.
29. Tili E and Michaille JJ: Resveratrol, micrornas, inflammation, and cancer. Journal of Nucleic Acids 2011, 102431, 2011.
30. Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, et al.: Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One 7, e51655, 2012.
31. Tome-Carneiro J, Larrosa M, Yanez-Gascon MJ, Dávalos A, Gil-Zamorano J, et al.: One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacological Research : The Official Journal of the Italian Pharmacological Society 72, 69-82, 2013.